Small Cell Carcinomas of the Gastrointestinal Tract

Textbook of Uncommon Cancer, Third Edition

Volumn , Issue , 2006, Pages 430-435

  Phan, Alexandria T ^a   Hoff, Paulo M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Extensive stage; Extrapulmonary; Gastrointestinal tract; Limited stage; Platinum chemotherapy; Poorly differentiated carcinoma; Review; Small cell carcinoma

Indexed keywords

EID: 78650507118     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470030542.ch38     Document Type: Chapter

References (83)

1. Livingston RB. Small cell carcinoma of the lung. Blood 1980; 56: 575-84.
2. Duguid J, Kennedy A. Oat-cell tumors of mediastinal glands. J Pathol Bacteriol 1930; 33: 93-9.
3. Ibrahim NB, Briggs JC, Corbishley CM. Extrapulmonary oat cell carcinoma. Cancer 1984; 54: 1645-61.
4. Remick SC, Hafez GR, Carbone PP. Extrapulmonary small-cell carcinoma. A review of the literature with emphasis on therapy and outcome. Medicine (Baltimore) 1987; 66: 457-71.
5. Fer MF, Greco FA, Oldham RK. Poorly differentiated neoplasms and tumors of unknown origin: introduction. Semin Oncol 1982; 9: 393-5.
6. McKeown F. Oat-cell carcinoma of the oesophagus. J Pathol Bacteriol 1952; 64: 889-91.
7. Brenner B, et al. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol 2004; 22: 2730-9.
8. Watson KJ, et al. Watery diarrhea-hypokalemia-achlorhydria syndrome and carcinoma of the esophagus. Gastroenterology 1985; 88: 798-803.
9. O'Byrne KJ, et al. Extrapulmonary small cell gastric carcinoma. A case report and review of the literature. Acta Oncol 1997; 36: 78-80.
10. Tateishi R, et al. Argyrophil cell carcinoma (apudoma) of the esophagus. A histopathologic entity. Virchows Arch A Pathol Anat Histol 1976; 371: 283-94.
11. Doherty MA, McIntyre M, Arnott SJ. Oat cell carcinoma of esophagus: a report of six British patients with a review of the literature. Int J Radiat Oncol Biol Phys 1984; 10: 147-52.
12. Thomas L, Kwok Y, Edelman MJ. Management of paraneoplastic syndromes in lung cancer. Curr Treat Options Oncol 2004; 5: 51-62.
13. Vrouvas J, Ash DV. Extrapulmonary small cell cancer. Clin Oncol (R Coll Radiol) 1995; 7: 377-81.
14. Van Der Gaast A, et al. Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas. Cancer 1990; 65: 422-4.
15. Bensch KG, et al. Oat-cell carcinoma of the lung. Its origin and relationship to bronchial carcinoid. Cancer 1968; 22: 1163-72.
16. Gould VE, et al. The APUD cell system and its neoplasms: observations on the significance and limitations of the concept. Surg Clin North Am 1979; 59: 93-108.
17. Skrabanek P, Powell D. Unifying concept of non-pituitary ACTHsecreting tumors: evidence of common origin of neural-crest tumors, carcinoids, and oat-cell carcinomas. Cancer 1978; 42: 1263-9.
18. Pearse AG. Common cytochemical and ultrastructural characteristics of cells producing polypeptide hormones (the APUD series) and their relevance to thyroid and ultimobranchial C cells and calcitonin. Proc R Soc Lond B Biol Sci 1968; 170: 71-80.
19. Pearse AG, Takor TT. Neuroendocrine embryology and the APUD concept. Clin Endocrinol (Oxf) 1976; 5(Suppl): 229S-244S.
20. Sidhu GS. The endodermal origin of digestive and respiratory tract APUD cells. Histopathologic evidence and a review of the literature. Am J Pathol 1979; 96: 5-20.
21. Bensch KG. The problem of classifying peripheral endocrine tumors. Hum Pathol 1983; 14: 383-5.
22. Arai K, Matsuda M. Gastric small-cell carcinoma in Japan: a case report and review of the literature. Am J Clin Oncol 1998; 21: 458-61.
23. Ho KJ, et al. Small cell carcinoma of the esophagus: evidence for a unified histogenesis. Hum Pathol 1984; 15: 460-8.
24. Jass J, Sobin LH. Histological typing of intestinal tumors. WHO International Histological Classification of Tumors. Berlin, Germany: Springer-Verlag, 1989.
25. Wick MR, Weatherby RP, Weiland LH. Small cell neuroendocrine carcinoma of the colon and rectum: clinical, histologic, and ultrastructural study and immunohistochemical comparison with cloacogenic carcinoma. Hum Pathol 1987; 18: 9-21.
26. Burke AB, Shekitka KM, Sobin LH. Small cell carcinomas of the large intestine. Am J Clin Pathol 1991; 95: 315-21.
27. Takubo K, et al. Primary undifferentiated small cell carcinoma of the esophagus. Hum Pathol 1999; 30: 216-21.
28. Maitra A, et al. Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases. Am J Surg Pathol 2001; 25: 595-601.
29. Sarsfield P, Anthony PP. Small cell undifferentiated ('neuroendocrine') carcinoma of the colon. Histopathology 1990; 16: 357-63.
30. WHO. The World Health Organization histological typing of lung tumours. Second edition. Am J Clin Pathol 1982; 77: 123-36.
31. Gaffey MJ, Mills SE, Lack EE. Neuroendocrine carcinoma of the colon and rectum. A clinicopathologic, ultrastructural, and immunohistochemical study of 24 cases. Am J Surg Pathol 1990; 14: 1010-23.
32. Yaziji H, Broghamer WL Jr. Primary small cell undifferentiated carcinoma of the rectum associated with ulcerative colitis. South Med J 1996; 89: 921-4.
33. Sarker AB, et al. An immunohistochemical and ultrastructural study of case of small-cell neuroendocrine carcinoma in the ampullary region of the duodenum. Acta Pathol Jpn 1992; 42: 529-35.
34. Bunn PA Jr, et al. Small cell lung cancer, endocrine cells of the fetal bronchus, and other neuroendocrine cells express the Leu-7 antigenic determinant present on natural killer cells. Blood 1985; 65: 764-8.
35. Lloyd RV, et al. Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors. Am J Pathol 1988; 130: 296-304.
36. Tapia FJ, et al. Neuron-specific enolase is produced by neuroendocrine tumours. Lancet 1981; 1: 808-11.
37. Ordonez NG. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol 2000; 24: 1217-23.
38. Ledermann JA. Extrapulmonary small cell carcinoma. Postgrad Med J 1992; 68: 79-81.
39. Carney D, McCann A, Corbally N. Molecular Genetics of Lung Cancer. Chichester, England: John Wiley and Sons, 1990.
40. Lam KY, et al. Esophageal small cell carcinomas: clinicopathologic parameters, p53 overexpression, proliferation marker, and their impact on pathogenesis. Arch Pathol Lab Med 2000; 124: 228-33.
41. Parwani AV, et al. Immunohistochemical and genetic analysis of nonsmall cell and small cell gallbladder carcinoma and their precursor lesions. Mod Pathol 2003; 16: 299-308.
42. Kelsen DP, et al. Small-cell carcinoma of the esophagus: treatment by chemotherapy alone. Cancer 1980; 45: 1558-61.
43. Einhorn LH. Initial therapy with cisplatin plus VP-16 in small-cell lung cancer. Semin Oncol 1986; 13: 5-9.
44. Batist G, et al. Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates. J Clin Oncol 1986; 4: 982-6.
45. Feld R, et al. Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. J Clin Oncol 1987; 5: 1401-9.
46. Wolf M, et al. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial. J Clin Oncol 1987; 5: 1880-9.
47. Bunn PA Jr, Carney DN. Overview of chemotherapy for small cell lung cancer. Semin Oncol 1997; 24: S7-69-S7-74.
48. Figoli F, et al. Cisplatin and etoposide as second-line chemotherapy in patients with small cell lung cancer. Cancer Invest 1988; 6: 1-5.
49. Mascaux C, et al. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. Lung Cancer 2000; 30: 23-36.
50. Maksymiuk AW, et al. Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial. J Clin Oncol 1994; 12: 70-6.
51. Morant R, Bruckner HW. Complete remission of refractory small cell carcinoma of the pancreas with cisplatin and etoposide. Cancer 1989; 64: 2007-9.
52. Jackson DV Jr, et al. Improvement of long-term survival in extensive small-cell lung cancer. J Clin Oncol 1988; 6: 1161-9.
53. Miranda FT, et al.: Paclitaxel/carboplatin/etoposide (PCE) therapy for advanced poorly differentiated neuroendocrine (PDNE) carcinoma: a Minnie Pearl Cancer Research Network phase II trial. In Proceedings of Clinical Oncology, Abstract 4058, 2005.
54. Hou Z, et al. A pilot study of irinotecan plus cisplatin in patients with metastatic high-grade neuroendocrine carcinoma. Proc Am Soc Clin Oncol 2003; 22: 375.
55. Ardizzoni A et al., The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group. Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. J Clin Oncol 1997; 15: 2090-6.
56. Sculier JP, et al. Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party. J Clin Oncol 1996; 14: 2337-44.
57. Turnbull AD, et al. Primary malignant tumors of the esophagus other than typical epidermoid carcinoma. Ann Thorac Surg 1973; 15: 463-73.
58. Horai T, et al. A cytologic study on small cell carcinoma of the esophagus. Cancer 1978; 41: 1890-6.
59. Huncharek M, Muscat J. Small cell carcinoma of the esophagu. The Massachusetts General Hospital experience, 1978 to 1993. Chest 1995; 107: 179-81.
60. Sabanathan S, Graham GP, Salama FD. Primary oat cell carcinoma of the oesophagus. Thorax 1986; 41: 318-21.
61. McFadden DW, Rudnicki M, Talamini MA. Primary small cell carcinoma of the esophagus. Ann Thorac Surg 1989; 47: 477-80.
62. Ohmura Y, et al. Small cell carcinoma of the esophagus: a case report. Jpn J Clin Oncol 1997; 27: 95-100.
63. Nichols GL, Kelsen DP. Small cell carcinoma of the esophagu. The Memorial Hospital experience 1970 to 1987. Cancer 1989; 64: 1531-3.
64. Rosenthal SN, Lemkin JA. Multiple small cell carcinomas of the esophagus. Cancer 1983; 51: 1944-6.
65. Craig SR, et al. Primary small-cell cancer of the esophagus. J Thorac Cardiovasc Surg 1995; 109: 284-8.
66. Medgyesy CD, et al. Small cell carcinoma of the esophagus: the University of Texas M. D. Anderson Cancer Center experience and literature review. Cancer 2000; 88: 262-7.
67. Madroszyk A, et al. Small-cell carcinoma of the esophagus: report of three cases and review of the literature with emphasis on therapy. Ann Oncol 2001; 12: 1321-5.
68. Yachida S, et al. Long-term survival after resection for small cell carcinoma of the esophagus. Ann Thorac Surg 2001; 72: 596-7.
69. Matsusaka T, Watanabe H, Enjoji M. Oat-cell carcinoma of the stomach. Fukuoka Igaku Zasshi 1976; 67: 65-73.
70. Matsui K, et al. Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. Am J Gastroenterol 1991; 86: 1167-75.
71. Bernatz P. Small Cell Neoplasm of the stomach: A Clinicopathologic Study, Graduate School. Minnesota: University of Minnesota, 1950.
72. Richardson RL, Weiland LH. Undifferentiated small cell carcinomas in extrapulmonary sites. Semin Oncol 1982; 9: 484-96.
73. Clery AP, Dockerty MB, Waugh JM. Small-cell carcinoma of the colon and rectum. A clinicopathologic study. Arch Surg 1961; 83: 164-72.
74. Hussein AM, et al. Small cell carcinoma of the large intestine presenting as central nervous systems signs and symptoms. Two case reports with literature review. J Neurooncol 1990; 8: 269-74.
75. Pazdur R, et al. Neuroendocrine small cell carcinomas in miscellaneous primary sites: implications for staging and therapy. Anticancer Res 1981; 1: 335-40.
76. Redman BG, Pazdur R. Colonic small cell undifferentiated carcinoma: a distinct pathological diagnosis with therapeutic implications. Am J Gastroenterol 1987; 82: 382-5.
77. Mills SE, Allen MS, Cohen AR Jr. Small-cell undifferentiated carcinoma of the colon. A clinicopathological study of five cases and their association with colonic adenomas. Am J Surg Pathol 1983; 7: 643-51.
78. Miller JR, Baggenstoss AH, Comfort MW. Carcinoma of the pancreas; effect of histological types and grade of malignancy on its behavior. Cancer 1951; 4: 233-41.
79. Cubilla AL, Fitzgerald PJ. Cancer of the pancreas (nonendocrine): a suggested morphologic classification. Semin Oncol 1979; 6: 285-97.
80. Wahid NA, et al. Response of small cell carcinoma of pancreas to a small cell lung cancer regimen: a case report. Cancer Invest 1996; 14: 335-9.
81. Toker C. Oat cell tumor of the small bowel. Am J Gastroenterol 1974; 61: 481-3.
82. Swanson PE, et al. Primary duodenal small-cell neuroendocrine carcinoma with production of vasoactive intestinal polypeptide. Arch Pathol Lab Med 1986; 110: 317-20.
83. Lee CS, Machet D, Rode J. Small cell carcinoma of the ampulla of vater. Cancer 1992; 70: 1502-4.